PAH Deficiency in Italy: Correlation of Genotype with Phenotype in the Sicilian Population

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 1996 Jan 1

PMID 8830172

Citations 6

Authors

V Romano

P Guldberg

F Guttler

C Meli

F Mollica

L Pavone

M Giovannini

E Riva

G Biasucci

D Luotti

L PALILLO

F Cali

N Ceratto

G Anello

P Bosco

Affiliations

Soon will be listed here.

Abstract

The results of the neonatal screening for phenylalanine hydroxylase (PAH) deficiency in Sicily show that its incidence is higher than previously reported for mainland Italians and that non-PKU HPA is in excess of classical and mild PKU. The latter finding suggests that a high number of non-PKU HPA mutations would occur in the Sicilian population compared to populations with an inverted PKU/non-PKU HPA ratio. Previous studies have identified 40 mutations accounting for the majority (98%) of mutant alleles underlying PAH deficiency in Sicily. In order to study the molecular basis of the distribution of PAH deficiency phenotypes in the Sicilian population, we have correlated 31 of those mutations with clinical and metabolic phenotypes in 12 mentally retarded patients, 14 treated patients with classic or mild PKU, and 13 subjects presenting the non-PKU HPA phenotype. The present study proposes a tentative classification for a large number (26) of PAH gene mutations which may represent an additional tool for establishing a differential diagnosis for PAH deficiency in the Sicilian population.

Citing Articles

A Novel Homozygous Mutation in a Patient with CDG Type Ig: New Report of a Case with a Mild Phenotype.

Nicotera A, Spoto G, Cali F, Romeo G, Musumeci A, Vinci M Mol Syndromol. 2021; 12(5):327-332.

PMID: 34602961 PMC: 8436637. DOI: 10.1159/000516606.

Mutations of the phenylalanine hydroxylase gene in Iranian patients with phenylketonuria.

Biglari A, Saffari F, Rashvand Z, Alizadeh S, Najafipour R, Sahmani M Springerplus. 2015; 4:542.

PMID: 26413448 PMC: 4579200. DOI: 10.1186/s40064-015-1309-8.

Screening of three Mediterranean phenylketonuria mutations in Tunisian families.

Khemir S, Siala H, Hadj Taieb S, Cherif W, Azzouz H, Kefi R J Genet. 2012; 91(1):91-4.

PMID: 22546830 DOI: 10.1007/s12041-012-0140-z.

Molecular basis of mild hyperphenylalaninaemia in Turkey.

Yilmaz E, Cali F, Roman V, OZALP I, Coskun T, Tokatli A J Inherit Metab Dis. 2000; 23(5):523-5.

PMID: 10947211 DOI: 10.1023/a:1005628717813.

A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.

Guldberg P, Rey F, Zschocke J, Romano V, Francois B, Michiels L Am J Hum Genet. 1998; 63(1):71-9.

PMID: 9634518 PMC: 1377241. DOI: 10.1086/301920.

References

Zschocke J, Graham C, Stewart F, Carson D, Nevin N . Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: frequent mutation allows screening and early diagnosis. Hum Mutat. 1994; 4(2):114-8. DOI: 10.1002/humu.1380040204. View

Koch R, Levy H, Matalon R, Rouse B, HANLEY W, Azen C . The North American Collaborative Study of Maternal Phenylketonuria. Status report 1993. Am J Dis Child. 1993; 147(11):1224-30. DOI: 10.1001/archpedi.1993.02160350098015. View

Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A . Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet. 1993; 2(10):1703-7. DOI: 10.1093/hmg/2.10.1703. View

Weinstein M, Eisensmith R, Abadie V, Avigad S, Lyonnet S, Schwartz G . A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria. Hum Genet. 1993; 90(6):645-9. DOI: 10.1007/BF00202483. View

Konecki D, Schlotter M, Trefz F, Lichter-Konecki U . The identification of two mis-sense mutations at the PAH gene locus in a Turkish patient with phenylketonuria. Hum Genet. 1991; 87(4):389-93. DOI: 10.1007/BF00197153. View

Okano Y, Eisensmith R, Guttler F, Lichter-Konecki U, Konecki D, Trefz F . Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 1991; 324(18):1232-8. DOI: 10.1056/NEJM199105023241802. View

Guttler F, Ledley F, Lidsky A, DiLella A, Sullivan S, Woo S . Correlation between polymorphic DNA haplotypes at phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria. J Pediatr. 1987; 110(1):68-71. DOI: 10.1016/s0022-3476(87)80290-1. View

Eisensmith R, Woo S . Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutat. 1992; 1(1):13-23. DOI: 10.1002/humu.1380010104. View

Ledley F . Clinical application of genotypic diagnosis for phenylketonuria: theoretical considerations. Eur J Pediatr. 1991; 150(11):752-6. DOI: 10.1007/BF02026704. View

10.

Dianzani I, Forrest S, Camaschella C, Saglio G, Ponzone A, Cotton R . Screening for mutations in the phenylalanine hydroxylase gene from Italian patients with phenylketonuria by using the chemical cleavage method: a new splice mutation. Am J Hum Genet. 1991; 48(3):631-5. PMC: 1682973. View

11.

Konecki D, Lichter-Konecki U . The phenylketonuria locus: current knowledge about alleles and mutations of the phenylalanine hydroxylase gene in various populations. Hum Genet. 1991; 87(4):377-88. DOI: 10.1007/BF00197152. View

12.

Economou-Petersen E, Henriksen K, Guldberg P, Guttler F . Molecular basis for nonphenylketonuria hyperphenylalaninemia. Genomics. 1992; 14(1):1-5. DOI: 10.1016/s0888-7543(05)80274-5. View

13.

Romeo G, Menozzi P, Ferlini A, Prosperi L, Cerone R, Scalisi S . Incidence of classic PKU in Italy estimated from consanguineous marriages and from neonatal screening. Clin Genet. 1983; 24(5):339-45. View

14.

Guthrie R, Susi A . A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963; 32:338-43. View

15.

Guldberg P, Henriksen K, Thony B, Blau N, Guttler F . Molecular heterogeneity of nonphenylketonuria hyperphenylalaninemia in 25 Danish patients. Genomics. 1994; 21(2):453-5. DOI: 10.1006/geno.1994.1296. View

16.

Avigad S, Kleiman S, Weinstein M, Cohen B, Schwartz G, Woo S . Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria. Am J Hum Genet. 1991; 49(2):393-9. PMC: 1683284. View

17.

Ramus S, Forrest S, PITT D, Saleeba J, Cotton R . Comparison of genotype and intellectual phenotype in untreated PKU patients. J Med Genet. 1993; 30(5):401-5. PMC: 1016377. DOI: 10.1136/jmg.30.5.401. View

18.

Svensson E, von Dobeln U, Eisensmith R, Hagenfeldt L, Woo S . Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr. 1993; 152(2):132-9. DOI: 10.1007/BF02072490. View

19.

Abadie V, Lyonnet S, Maurin N, BERTHELON M, Caillaud C, Giraud F . CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics. 1989; 5(4):936-9. DOI: 10.1016/0888-7543(89)90137-7. View

20.

Kaufman S, Max E, Kang E . Phenylalanine hydroxylase activity in liver biopsies from hyperphenylalaninemia heterozygotes: deviation from proportionality with gene dosage. Pediatr Res. 1975; 9(8):632-4. DOI: 10.1203/00006450-197508000-00004. View